Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92,189,700
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
30,588,325
-
Shares change
-
+768,356
-
Total reported value, excl. options
-
$457,556,044
-
Value change
-
-$490,819
-
Put/Call ratio
-
72.71%
-
Number of buys
-
56
-
Number of sells
-
-32
-
Price
-
$15.09
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q4 2021
114 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q4 2021.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30,588,325 shares
of 92,189,700 outstanding shares and own 33.18% of the company stock.
Largest 10 shareholders include PFM Health Sciences, LP (4,092,309 shares), FMR LLC (3,323,284 shares), FARALLON CAPITAL MANAGEMENT LLC (2,963,448 shares), Avidity Partners Management LP (2,674,067 shares), PICTET ASSET MANAGEMENT SA (1,916,431 shares), BlackRock Inc. (1,763,029 shares), ALKEON CAPITAL MANAGEMENT LLC (1,246,625 shares), JANUS HENDERSON GROUP PLC (1,172,725 shares), VANGUARD GROUP INC (914,516 shares), and FIL Ltd (860,667 shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.